A patient with recurrent atrial fibrillation and monomorphic ventricular tachycardia treated successfully with dronedarone.

摘要

We report on a patient with ischaemic cardiomyopathy who had received an implantable cardioverter-defibrillator for recurrent ventricular tachycardia (VT). He also developed paroxysmal atrial fibrillation (AF) which led to therapy with dronedarone. As demonstrated by the device memory, the drug not only suppressed AF but also completely suppressed VT. Patients with advanced structural heart disease often suffer from atrial fibrillation (AF) and from ventricular arrhythmias. Although implantable cardioverter-defibrillator (ICD) therapy and catheter ablation are often used to treat ventricular tachycardia (VT), some patients continue to have frequent VT episodes triggering ICD therapy. Frequent ICD shocks, however, result in significant impairment of quality of life and may further impair left ventricular function. Thus, many patients continue to need antiarrhythmic drug therapy. We report here on such a patient who was intolerant to amiodarone and was subsequently treated with dronedarone.